Case Presentation - Biventricular Hypertrophy and Valvular Pulmonary Stenosis in Adult Patient with Noonan Syndrome: A Rare Case
Versions
- 2021-09-30 (2)
- 2021-09-30 (1)
Downloads
Introduction: Noonan syndrome (NS) is a genetic disorder often accompanied by multiple congenital abnormalities. The prevalence of NS at live birth has been reported as one in 1000-2500 individuals. About 80% of patients with Noonan syndrome have abnormalities in the cardiovascular system. Case presentation:41-year-old Javanese male presented with chief complaint shortness of breath. His Body Mass Index (BMI) was 18,3. He had an oval-shaped face with a short neck, thin hair, and prominent nasolabial fold. Echocardiography showed biventricular hypertrophy alongside pulmonary valve stenosis, pulmonary regurgitation and minimal pericardial effusion. Discussion: In 1962, Jacqueline Noonan, a pediatric cardiologist, identified 9 patients whose faces were very similar, had short stature, significant chest deformities, and with pulmonary stenosis. Noonan syndrome is a relatively common non-chromosomal syndrome that is similar to the phenotype of Turner's syndrome and presents with cardiovascular malformations. Adult with NS has distinctive facial features such as ptosis, wide eyes, low posterior rotation of ears and helical thickening, and a wide neck.Pulmonary stenosis is the most common heartdefect found in NS, besides HCM isalsoquitecommon inabout20% of patients. We reported a case of a patient with typical characteristics of NS such as pulmonary valve stenosis accompanied by biventricular ventricular hypertrophyand its typical face who survived through adulthood. Conclusion: Syndrome Noonan in the adult is quite rare and difficult to diagnose. We reported a case of an adult man with facial appearance and echocardiographic findings identical with Noonan Syndrome.
Keywords: Adult, Biventricular hypertrophy, Noonan Syndrome, Pulmonary valve stenosis
Mendez HMM, Opitz JM. 1985. Noonan syndrome: A review. Am J Med Genet.21:493–506
Bhambhani V, Muenke M, Human N, Institutes N. Noonan Syndrome. 2014;37–43.
Smpokou P, Tworog-dube E, Kucherlapati RS, Roberts AE. Medical Complications, Clinical Findings, and Educational Outcomes in Adults With Noonan Syndrome. 2012;3106–11.
Shaw A, Kalidas K, Crosby A, Jeffery S, Patton M. 2007. The natural history of Noonan syndrome: A long-term follow-up study. Arch Dis Child 92:128–132.
Romano AA, Allanson JE, Dahlgren J, et al. Noonan syndrome: clinical features, diagnosis, and management guidelines. Pediatrics. 2010;126(4):746-759.
Sreeram N, Kitchiner D, Smith A: Spectrum of valvular abnormalities in Noonan's syndrome: A pathologic study. Cardiol Young 1994; 4: 62–66.
Ehlers KH, Engle MA, Levin AR, Deely WJ: Eccentric ventricular hypertrophy in familial and sporadic instances of 46 XX, XY Turner phenotype. Circulation 1972; 45: 639–652.
Burch M, Sharland M, Shinebourne E, Smith G, Patton MA, McKenna WJ. Cardiologic abnormalities in Noonan syndrome: phenotypic diagnosis and echocardiographic assessment of 118 patients. J Am Coll Cardiol. 1993;22(4):1189–1192.
Pandit B, Sarkozy A, Pennacchio LA, et al. Gain-of-function RAF1 mutations cause Noonan and LEOPARD syndromes with hypertrophic cardiomyopathy. Nat Genet. 2007;39(8):1007–1012.
Noonan JA, Ehmke DA. Associated noncardiac malformations in children with congenital heart disease. J Pediatr. 1963;31: 150–153.
Sharland M, Burch M, McKenna WM, Paton MA: A clinical study of Noonan syndrome. Arch Dis Child 1992; 67: 178–183.
Allanson JE. Noonan Syndrome. 2007;279:274–9.
Yoshida R, Hasegawa T, Hasegawa Y, et al. Protein-tyrosine phosphatase, nonreceptor type 11 mutation analysis and clinical assessment in 45 patients with Noonan syndrome. J Clin Endocrinol Metab. 2004; 89(7):3359–3364
Tartaglia M, Pennacchio LA, Zhao C, et al. Gain-of-function SOS1 mutations cause a distinctive form of Noonan syndrome. Nat Genet. 2007;39(1):75–79
Tartaglia M, Mehler EL, Goldberg R, et al. Mutations in PTPN11, encoding the protein tyrosine phosphatase SHP-2, cause Noonan syndrome. Nat Genet. 2001;29(4): 465– 468
Roberts AE, Araki T, Swanson KD, et al. Germline gain-of-function mutations in SOS1 cause Noonan syndrome. Nat Genet. 2007;39(1):70–74
Zenker M, Buheitel G, Rauch R, et al. Genotype-phenotype correlations in Noonan syndrome. J Pediatr. 2004;144(3): 368–374.
Raaijmakers R, Noordam C, Noonan JA, Croonen EA, van der Burgt CJ, Draaisma JM. Are ECG abnormalities in Noonan syndrome characteristic for the syndrome? Eur J Pediatr. 2008;167(12):1363–1367
Van der Burgt, I. (2007). "Noonan syndrome." Orphanet J Rare Dis 2: 4.
Lee NB, Kelly L, Sharland M. 1992. Ocular manifestations of Noonan syndrome. Eye 6:328–334.
Witt DR, Hoyme HE, Zonana J, Manchester DK, Fryns JP, Stevenson JG, Curry CJR, Hall JG. 1987. Lymphedema in Noonan syndrome: Clues to pathogenesis and prenatal diagnosis and review of the literature. Am J Med Genet 27:841–856
Sharland M, Patton MA, Talbot S, Chitolie A, Bevan DH. 1992. Coagulation-factor deficiencies and abnormal bleeding in Noonan's syndrome. Lancet 339:19–21.
Copyright (c) 2021 Tinton Pristianto, Rosi Amrilla Fagi
This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.
- Cardiovascular and Cardiometabolic Journal (CCJ) is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License
-
Authors who publish with Cardiovascular and Cardiometabolic Journal (CCJ) agree to the following terms:
-
The journal allows the author to hold the copyright of the article without restrictions.
-
The journal allows the author(s) to retain publishing rights without restrictions.
-
The legal formal aspect of journal publication accessibility refers to Creative Commons Attribution ShareAlike 4.0 International License (CC BY-SA).
